319 related articles for article (PubMed ID: 12507935)
1. Association of p16(INK4a) and pRb inactivation with immortalization of human cells.
Tsutsui T; Kumakura S; Yamamoto A; Kanai H; Tamura Y; Kato T; Anpo M; Tahara H; Barrett JC
Carcinogenesis; 2002 Dec; 23(12):2111-7. PubMed ID: 12507935
[TBL] [Abstract][Full Text] [Related]
2. Immortalization of normal human embryonic fibroblasts by introduction of either the human papillomavirus type 16 E6 or E7 gene alone.
Yamamoto A; Kumakura S; Uchida M; Barrett JC; Tsutsui T
Int J Cancer; 2003 Sep; 106(3):301-9. PubMed ID: 12845665
[TBL] [Abstract][Full Text] [Related]
3. p16/pRb pathway alterations are required for bypassing senescence in human prostate epithelial cells.
Jarrard DF; Sarkar S; Shi Y; Yeager TR; Magrane G; Kinoshita H; Nassif N; Meisner L; Newton MA; Waldman FM; Reznikoff CA
Cancer Res; 1999 Jun; 59(12):2957-64. PubMed ID: 10383161
[TBL] [Abstract][Full Text] [Related]
4. Human keratinocytes that express hTERT and also bypass a p16(INK4a)-enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics.
Dickson MA; Hahn WC; Ino Y; Ronfard V; Wu JY; Weinberg RA; Louis DN; Li FP; Rheinwald JG
Mol Cell Biol; 2000 Feb; 20(4):1436-47. PubMed ID: 10648628
[TBL] [Abstract][Full Text] [Related]
5. Keratinocyte growth conditions modulate telomerase expression, senescence, and immortalization by human papillomavirus type 16 E6 and E7 oncogenes.
Fu B; Quintero J; Baker CC
Cancer Res; 2003 Nov; 63(22):7815-24. PubMed ID: 14633708
[TBL] [Abstract][Full Text] [Related]
6. Long-term cultured IL-2-dependent T cell lines demonstrate p16(INK4a) overexpression, normal pRb/p53, and upregulation of cyclins E or D2.
Siwicki JK; Hedberg Y; Nowak R; Lodén M; Zhao J; Landberg G; Roos G
Exp Gerontol; 2000 May; 35(3):375-88. PubMed ID: 10832057
[TBL] [Abstract][Full Text] [Related]
7. Protection against chemotherapy-induced cytotoxicity by cyclin-dependent kinase inhibitors (CKI) in CKI-responsive cells compared with CKI-unresponsive cells.
Schmidt M; Fan Z
Oncogene; 2001 Sep; 20(43):6164-71. PubMed ID: 11593424
[TBL] [Abstract][Full Text] [Related]
8. Immortalization of bovine capillary endothelial cells by hTERT alone involves inactivation of endogenous p16INK4A/pRb.
Veitonmäki N; Fuxe J; Hultdin M; Roos G; Pettersson RF; Cao Y
FASEB J; 2003 Apr; 17(6):764-6. PubMed ID: 12586745
[TBL] [Abstract][Full Text] [Related]
9. Papillomavirus type 16 E6/E7 and human telomerase reverse transcriptase in esophageal cell immortalization and early transformation.
Zhang H; Jin Y; Chen X; Jin C; Law S; Tsao SW; Kwong YL
Cancer Lett; 2007 Jan; 245(1-2):184-94. PubMed ID: 16488074
[TBL] [Abstract][Full Text] [Related]
10. Abrogation of the retinoblastoma tumor suppressor checkpoint during keratinocyte immortalization is not sufficient for induction of centrosome-mediated genomic instability.
Piboonniyom SO; Duensing S; Swilling NW; Hasskarl J; Hinds PW; Münger K
Cancer Res; 2003 Jan; 63(2):476-83. PubMed ID: 12543805
[TBL] [Abstract][Full Text] [Related]
11. Telomere-based proliferative lifespan barriers in Werner-syndrome fibroblasts involve both p53-dependent and p53-independent mechanisms.
Davis T; Singhrao SK; Wyllie FS; Haughton MF; Smith PJ; Wiltshire M; Wynford-Thomas D; Jones CJ; Faragher RG; Kipling D
J Cell Sci; 2003 Apr; 116(Pt 7):1349-57. PubMed ID: 12615976
[TBL] [Abstract][Full Text] [Related]
12. The p16(INK4A)/pRb pathway and telomerase activity define a subgroup of Ph+ adult Acute Lymphoblastic Leukemia associated with inferior outcome.
Chien WW; Catallo R; Chebel A; Baranger L; Thomas X; Béné MC; Gerland LM; Schmidt A; Beldjord K; Klein N; Escoffre-Barbe M; Leguay T; Huguet F; Larosa F; Hayette S; Plesa A; Ifrah N; Dombret H; Salles G; Chassevent A; Ffrench M
Leuk Res; 2015 Apr; 39(4):453-61. PubMed ID: 25675863
[TBL] [Abstract][Full Text] [Related]
13. Genetic and epigenetic changes in human epithelial cells immortalized by telomerase.
Farwell DG; Shera KA; Koop JI; Bonnet GA; Matthews CP; Reuther GW; Coltrera MD; McDougall JK; Klingelhutz AJ
Am J Pathol; 2000 May; 156(5):1537-47. PubMed ID: 10793065
[TBL] [Abstract][Full Text] [Related]
14. Alterations of INK4a(p16-p14ARF)/INK4b(p15) expression and telomerase activation in meningioma progression.
Simon M; Park TW; Köster G; Mahlberg R; Hackenbroch M; Boström J; Löning T; Schramm J
J Neurooncol; 2001 Dec; 55(3):149-58. PubMed ID: 11859969
[TBL] [Abstract][Full Text] [Related]
15. Methylation of the p16(INK4a) promoter region in telomerase immortalized human keratinocytes co-cultured with feeder cells.
Darbro BW; Lee KM; Nguyen NK; Domann FE; Klingelhutz AJ
Oncogene; 2006 Nov; 25(56):7421-33. PubMed ID: 16767161
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus type 16 E6 promotes retinoblastoma protein phosphorylation and cell cycle progression.
Malanchi I; Accardi R; Diehl F; Smet A; Androphy E; Hoheisel J; Tommasino M
J Virol; 2004 Dec; 78(24):13769-78. PubMed ID: 15564485
[TBL] [Abstract][Full Text] [Related]
17. Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells.
Kiyono T; Foster SA; Koop JI; McDougall JK; Galloway DA; Klingelhutz AJ
Nature; 1998 Nov; 396(6706):84-8. PubMed ID: 9817205
[TBL] [Abstract][Full Text] [Related]
18. Absence of cancer-associated changes in human fibroblasts immortalized with telomerase.
Morales CP; Holt SE; Ouellette M; Kaur KJ; Yan Y; Wilson KS; White MA; Wright WE; Shay JW
Nat Genet; 1999 Jan; 21(1):115-8. PubMed ID: 9916803
[TBL] [Abstract][Full Text] [Related]
19. Induction of p16INK4A mediated by beta-catenin in a TCF4-independent manner: implications for alterations in p16INK4A and pRb expression during trans-differentiation of endometrial carcinoma cells.
Saegusa M; Hashimura M; Kuwata T; Hamano M; Okayasu I
Int J Cancer; 2006 Nov; 119(10):2294-303. PubMed ID: 16858682
[TBL] [Abstract][Full Text] [Related]
20. A two-stage, p16(INK4A)- and p53-dependent keratinocyte senescence mechanism that limits replicative potential independent of telomere status.
Rheinwald JG; Hahn WC; Ramsey MR; Wu JY; Guo Z; Tsao H; De Luca M; Catricalà C; O'Toole KM
Mol Cell Biol; 2002 Jul; 22(14):5157-72. PubMed ID: 12077343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
